Bio::Neos

Executive Summary

Bio::Neos is a US-based biotechnology software development company founded in 2015 that positions itself as a 'Scientific Technology Architect.' The firm specializes in creating custom digital platforms and web applications for clients in the life sciences and digital health sectors. By leveraging a team with strong life science backgrounds, Bio::Neos bridges the gap between scientific research and technology, delivering tailored, agile solutions that enable clients to accelerate innovation. The company's mission is to support the creation of life-saving and life-enhancing products through innovative technology, making it a key enabler for drug discovery, clinical trials, and digital health initiatives. Despite being privately held with no disclosed funding rounds, Bio::Neos has built a reputation for high-quality, science-driven software engineering, serving a diverse client base ranging from startups to established biopharma organizations. The company operates from Kansas City, United States, and focuses on combining domain expertise with modern software development practices, including AI and machine learning capabilities, to solve complex scientific challenges. As a service-based model, its growth is tied to client demand and repeat business, offering a stable but less scalable investment profile compared to product-driven biotechs.

Upcoming Catalysts (preview)

• Q2 2026Major Client Win with Top-20 Pharmaceutical Company35% success
• H2 2026Launch of Proprietary AI-Driven Drug Discovery Platform40% success